Sanara MedTech Inc. and Biomimetic Innovations Ltd announced that the U.S. Patent and Trademark Office has granted U.S. Patent No. 12,251,490 for OsStic™, a synthetic injectable structural bio-adhesive. The patent covers key ingredients and methods related to aqueous compositions, bone fillers, and biological tissue adhesives, as well as kits and prefilled syringes for the inventive composition. This new patent extends protection for OsStic through 2037 and adds to the existing portfolio, which includes another granted patent for bonding soft tissues. Additional applications are pending to further protect related technologies beyond 2040.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanara Medtech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9600037-en) on December 10, 2025, and is solely responsible for the information contained therein.